Archived Insight | September 20, 2023

Proposed MHPAEA Rules and the Challenges They Would Create

The Departments of Labor, HHS and Treasury recently released an extensive package of guidance, including proposed rules for mental health parity and substance use disorder parity under the Mental Health Parity and Addiction Equity Act (MHPAEA). These rules propose significant changes to the 2013 MHPAEA final regulations as well as new, additional regulatory requirements.

Watch the webinar to learn more about these proposed rules and what they could mean for health plan benefits.

Proposed MHPAEA Rules and the Challenges They Would Create

You’ll get:

  • An overview of MHPAEA, including highlights of the recent federal guidance package
  • Details of the proposed rules
  • Key takeaways for your health plan

Webinar replay

 

Get the slides

Don’t have time to watch a video right now? No worries. Here is a copy of the slides from this session.

Download Now

Speakers

Elena Lynett
Elena Lynett, JD
Senior Vice President
National Health Compliance
Eric Miller
Eric Miller, FSA, CERA, MAAA,
Vice President and Consulting Actuary
National Health Consulting and Analytics
Julia Zuckerman
Julia Zuckerman, JD
Vice President and Senior Consultant
National Health Compliance

 

See more insights

Black Female Pharmacist Observes Medicines On Shelves In A Pharmacy

PBM Transparency, Fiduciary Risk & Emerging Compliance Issues: A 2026 Update for Plan Sponsors

A practical webinar for plan sponsors on PBM transparency, fiduciary risk and emerging compliance issues affecting pharmacy benefits.
Two Businesspeople Working Together On A Laptop In The Office

Why Oversight of Vendors’ AI Use Is a Governance Essential

When vendors add AI features, risk profiles can shift quietly. Learn how structured oversight makes vendor AI use visible and governable.
Business People Having A Meeting In Office Boardroom

Evaluating the Impact and Outcomes of Point Solutions

Learn how plan sponsors can evaluate healthcare point solutions by measuring ROI, costs and outcomes using data and clinical evidence.

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.

Don't miss out. Join 16,000 others who already get the latest insights from Segal.